For research use only. Not for use in diagnostic procedures.
In 10 percent of the patients with high blood pressure and around 20 percent of the patients with therapy resistant hypertonia, the underlying cause is primary hyper-aldosteronism (PHA). It can be detected by estimation of serum aldosterone and renin levels. The ratio helps to differentiate it from secondary hyper-aldosteronism. Furthermore, it’s important to rule out another differential causing sodium retention and hypertension:
For Research Use Only. Not For Use In Diagnostic Procedures.
The individual product regulatory statements may vary, please refer to the instructions for use for more information.
|568||ELISA||Plasma Renin Activity (PRA)|| antibody-coated